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Newcastle disease virus selectively infects 
dividing cells and promotes viral proliferation
Zhili Chu1,2†, Xiaolong Gao1†, Haijin Liu1, Jiangang Ma1, Caiying Wang1, Kejia Lu1, Qingsong Han1, 
Yanhong Wang1, Chongyang Wang1, Fathalrhman E. A. Adam1,3, Xinglong Wang1, Sa Xiao1 and Zengqi Yang1*
Abstract 
Newcastle disease virus (NDV) can select cells to infect, but the mechanism of its cell selectivity has not been compre-
hensively investigated. Here, we use HeLa cells to establish that NDV can selectively infect cells at the single-cell level. 
We labeled proliferating cells with 5′-bromo-2-deoxyuridine (BrdU) and examined the colocalization of BrdU with NDV 
in cells to clarify the relationships between NDV infection and cell proliferation. Receptors at the plasma membrane 
mediate NDV entry into host cells. We labeled sialic acid receptor isoforms, compared their densities between differ-
ent cell types and measured the sialic acid receptor densities in different cell phases. Our results suggest that NDV 
displays host tropism to HeLa cells compared to BHK cells and that the differences in the receptor isoform expres-
sion patterns between cell types contribute to the selection of HeLa by NDV. At the single-cell level, the dynamics of 
receptor expression changes during different cell phases contributing to the selection of cells in S/G2 phase for NDV 
infection. Furthermore, cell proliferation benefits viral replication, and enhanced virus replication leads to increased 
damage to cells. The elucidation of the mechanisms underlying host cell selection by NDV may help in the screening 
and characterizing of additional candidate oncolytic virus strains.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Newcastle disease (ND), which is caused by the Newcas-
tle disease virus (NDV), is one of the most severe avian 
diseases and can cause great economic loss to the poultry 
industry worldwide [1]. ND is a contagious disease, and 
NDV can infect a wide range of domestic and wild birds 
and kinds of cells. Viruses have evolved to manipulate 
and take control of the programmed cell death response, 
but the infected cell attempts to neutralize viral infec-
tions by activating different stress signals and defensive 
pathways to antagonize virus-induced cell self-destruc-
tion [1]. Both extrinsic and intrinsic apoptotic pathways 
can be activated in cells after NDV infection [2], and 
NDV-induced cell death predominantly occurs via apop-
tosis [2–5]. As an oncolytic virus, NDV is a promising 
agent for cancer treatment, and its lytic nature makes it 
effective in identifying and destroying malignant cells [6]. 
In the early 1950s, NDV became a promising oncolytic 
agent [7, 8]. Since then, NDV has been extensively inves-
tigated for its use in cancer treatment [9–11]. In 1968, the 
first attenuated NDV vaccine to be systematically admin-
istrated was given to several patients with metastatic 
carcinoma [12]. To date, NDV has been widely used as a 
cancer vaccine and an oncolytic agent in several clinical 
trials of certain human cancers [13–17]. NDV can selec-
tively infect cells, but the mechanism of its cell selectivity 
has not been comprehensively investigated.
During viral infection, the first challenge that viruses 
must overcome is gaining access to the intracellular 
machinery, and the infection process starts when the 
virus interacts with a target receptor on the host cell, 
after which the initial steps of virus entry begin [18]. 
Sialic acids (Sias) represent a family of sugar molecules, 
with N-acetylneuraminic acid (Neu5Ac) as the most com-
mon variant [19]. NDV binds to the Sia receptor on host 
cells and can infect a broad range of cell types and this 
replication process kills the host cells [20]. However, no 
study has specifically examined whether NDV selectively 
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infects cells because of differences in the expression pat-
tern of Sia receptors in different cell cycles.
The eukaryotic cell cycle is generally divided into four 
stages: gap 1 phase (G1), synthesis phase (S), gap 2 phase 
(G2), and mitotic phase (M); DNA synthesis takes place 
in the S phase, generating exactly two identical sister 
chromosomes; G2 phase is a period of rapid cell growth 
and protein synthesis during which cells get ready for 
mitosis [21]. In sharp contrast to normal cells that only 
divide a finite number of times, cancer cells never cease 
to proliferate. Proliferation is one of the hallmarks of 
cancer cells, and this perhaps due to the aberrant modi-
fication in glycosylation, particularly that in terminal sia-
lylation correlates with tumorigenic transformation and 
progression [22]. The proliferation activity of cancer cells 
is often used as a promising therapeutic target for can-
cer in clinical applications. For cancer cells, it is still not 
entirely understood whether oncolytic viruses can target 
its proliferation characteristics and select proliferative 
cells.
In the present study, by using single-cell and mixed 
culture experiments, we tested the relationship among 
host receptors, cell proliferation and NDV selectivity. 
Our hypothesis was that the cell selectivity of NDV ben-
efits its replication. Dynamic changes in the Sia receptor 
profile between different cell types and cell phases, along 
with cell proliferation status, were shown to be important 
factors responsible for the cell selectivity of NDV.
Materials and methods
Animal experiments and ethics statements
The protocol in this study was approved by the Com-
mittee on the Ethics of Animal Care and Use of the 
National Research Center for Veterinary Medicine (Per-
mit 20160313088). All animal works complied with the 
guidelines of the Animal Care and Use Committee of 
Northwest A&F University after prior approval.
Cell culture and virus
The HeLa and BHK-21 (BHK) cells used in this study 
were stored in our laboratory. BHK-RFP and HeLa-RFP 
cells were produced by transfecting BHK/HeLa cells with 
pCDH-CMV-MCS-EF1-RFP before use. All cells were 
maintained in DMEM (Sigma) supplemented with 10% 
(or 5%, 2% or 0% where indicated) fetal bovine serum 
(FBS), 100 U/mL penicillin, 0.1  mg/mL streptomycin, 
2  mM  l-glutamine (Invitrogen), 1% nonessential amino 
acids (Invitrogen), and 0.1  mM β-mercaptoethanol 
(Sigma). The La Sota and F48E9 NDV strains were used 
in this study. La Sota is a standard genotype II lentogenic 
NDV strain, and F48E9 is a standard genotype IX NDV 
strain in China. These two strains were propagated in 
the allantoic cavity of 9- to 11-day-old SPF embryonated 
chicken eggs, and all allantoic fluid samples were har-
vested and stored at −70 °C until further use [23].
Flow cytometry
For cell cycle analysis, cells were harvested and washed 
twice with PBS. Cells were digested by trypsin for a rela-
tively long time (5  min), until almost all cells were in a 
unicellular state. After rinsing, the cells were suspended 
and fixed with 75% ice-cold ethanol for 24 h at 4 °C. Then, 
the cells were centrifuged at 600 g for 10 min and washed 
with PBS. Finally, the cells were resuspended in 500 µL of 
PBS containing 50 µg/mL propidium iodide (PI), 100 µg/
mL RNase (MP Biomedicals) and 0.037  mg/mL EDTA 
(MP Biomedicals) and incubated at 37 °C for 30 min. The 
prepared samples were analyzed using a FACS (FACS-
Calibur, BD). Apoptotic cell death was detected by the 
Annexin V/PI staining assay (HeYan Biotech Ltd., Shang-
hai) according to the manufacturer’s protocols. Briefly, 
cells were harvested and washed twice with PBS. Then, 
the cells were suspended in 400 µL of binding buffer, fol-
lowed by incubation with 5 µL Annexin V per sample for 
15 min. Subsequently, 10 µL of PI per sample was added, 
and the samples were analyzed via FACS (FACSCalibur, 
BD, USA). The data were analyzed using FlowJo software 
(Tree Star, Ashland, OR, USA).
Immunofluorescence and immunocytochemical analyses
BrdU is commonly used in studies of DNA replication 
and cell proliferation [24]. To understand whether NDV 
selectively infects dividing cells, we labeled the cells 
with BrdU (5 μM) and infected the cells with the La Sota 
NDV strain (0.1 MOI) for 16 h (La Sota) or 12 h (F48E9). 
For BrdU immunofluorescence, cell samples were fixed 
with 4% paraformaldehyde (PFA) for 15  min. After 
the cells were washed three times with PBS, they were 
treated with 2  M hydrochloric acid in ultrapure water 
for 30  min at room temperature, followed by the addi-
tion of 0.2% sodium borate solution and another incu-
bation for 30  min at room temperature. Then, the cells 
were blocked with 1% BSA for 30 min and then incubated 
with a primary antibody against BrdU (1:100 dilution; 
BOSHIDE, China) and a chicken polyclonal anti-NDV 
serum (1:500 dilution; prepared in our laboratory) over-
night at 4  °C. The next day, the cells were washed three 
times in PBS and treated with Alexa  Fluor® 488-conju-
gated goat anti-chicken IgY H&L (1:500 dilution; Abcam, 
Cambridge, UK) and Alexa Fluor 594-conjugated donkey 
anti-mouse secondary antibodies (1:500 dilution; Invitro-
gen, Carlsbad, CA, USA) for 1 h at room temperature in a 
dark box. Finally, nuclei were stained with Hoechst 33342 
(5 µg/mL) for 5 min. Images viewed on a Leica fluores-
cence microscope or an Andor Revolution WD confocal 
microscope was captured. For quantification of the GFP/
Page 3 of 13Chu et al. Vet Res           (2019) 50:27 
RFP ratio by flow cytometry, the cells were harvested and 
washed twice with PBS. Chicken polyclonal anti-NDV 
and mouse anti-RFP primary antibodies (1:300 dilu-
tion; Bioss; Beijing; China) were used in this experiment. 
Fluorescence staining was performed in a test tube, and 
the staining procedure was performed as previously 
described [25]. In particular, to wash the cells, centrifuga-
tion was conducted five times between each step.
RNA and q‑PCR
Total RNA was extracted with Trizol reagent (Takara, 
Dalian, China). Single-stranded cDNA was prepared 
from 0.5  µg of RNA using a reverse transcription kit 
(Takara, Dalian, China), and specific gene expression lev-
els were then analyzed using q-PCR. The amplification 
conditions for q-PCR (Gene Star, Beijing, China) were as 
follows: initial denaturation at 94 °C for 10 min, 40 cycles 
of 94 °C for 30 s and 72 °C for 60 s, and a final extension 
at 72  °C for 10  min. The primers used in this study are 
shown in Table 1.
Detection of Sias by lectin staining assay
α2,3 and α2,6 N-linked Sias allow for efficient interac-
tion of NDV with target cells [27]. SNA binds preferen-
tially to Sias attached to terminal galactose through the 
α2,6 linkage and, to a lesser degree, α2,3 linkage. MAL1 
binds to Gal (β-1,4) GlcNAc but tolerates the substitu-
tion of N-acetyllactosamine with Sia at the 3 position of 
galactose. After harvesting, cells were fixed with 4% PFA 
at room temperature for 30 min. Lectin staining was per-
formed with fluorescein-labeled Maackia amurensis lec-
tin I (MAL1; Vector Laboratories, San Mateo, CA, USA) 
and Sambucus nigra lectin (SNA; Vector Laboratories, 
CA, USA) according to the manufacturer’s instructions. 
MAL1 binds to Gal (β-1,4) GlcNAc but tolerates the sub-
stitution of N-acetyllactosamine with Sia at the 3 posi-
tion of galactose, while SNA binds to α2,6-linked Sia. The 
respective lectins were added to the cell cultures, and 
the samples were incubated at 37 °C for 30 min and then 
rinsed three times with PBS. The binding of the labeled 
lectins to cells was detected using flow cytometry.
Viral plaque assay
The viral titer was measured by the plaque assay. Briefly, 
confluent monolayers of BHK cells cultured in 24-well 
plates were inoculated with cell supernatants at different 
dilutions (0.1–10  µL per well). After adsorption for 1  h 
at 37  °C and 5%  CO2, the liquid was aspirated, and the 
cells were overlaid with DMEM containing 2% FBS and 
1% methyl cellulose and cultured at 37  °C and 5%  CO2. 
After 3 to 5 days, the medium was removed, and the cells 
were lightly washed three times with PBS and fixed with 
4% PFA for 30 min. Finally, the plaques were stained with 
crystal violet. Manual counting of viral plaque and data 
shown are mean ± SD of three independent experiments.
Western blot analysis
Proteins were extracted from transfected cells or NDV-
infected cells. After the protein samples were boiled 
for 5 min in 5% SDS–PAGE sample loading buffer, they 
were separated by SDS-PAGE and transferred to a PVDF 
membrane for Western blotting. Briefly, the membrane 
was blocked with 10% skim milk for 12 h at 4  °C. Then, 
antibodies against BAX, Bcl2, caspase-3 and GAPDH 
were applied at different dilutions (BAX: 1:500 dilu-
tion; Bcl2: 1:500 dilution; caspase-3: 1:500 dilution; and 
GAPDH: 1:1000 dilution) to detect the proteins. After 
a 12-h incubation at 4  °C, the membrane was washed 
three times with Tris-buffered saline containing Tween-
20 (TBST). Subsequently, the membrane was incubated 
with HRP-conjugated anti-rabbit/mouse IgG (1:3000) for 
1 h at 37 °C. After four additional washes with TBST, the 
immunoreactive protein bands were visualized with an 
ECL Western blotting detection reagent (Bio-Rad), and 
the results were analyzed using a Tanon-410 automated 
gel imaging system.
Statistical analysis
The Student’s t test was used when only two groups of 
data were compared. All data are presented as the means 
and SD, and the statistical significance of differences is 
reported as follows: *P < 0.05; **P < 0.01; and ***P < 0.001. 
All data are representative of no fewer than three 
Table 1 Primer table. 
Name Forward primer (5′–3′) Reverse primers (5′–3′)
NDV M gene [26] AAG AAG CAA ATC GCCCC ACG CTT CCT AGG CAGAG 
Human Caspase-3 TGC ATA CTC CAC AGC ACC TG TTC TGT TGC CAC CTT TCG GT
Human Caspase-9 AGC AGC AAA GTT GTC GAA GC TTC TGC TCG ACA TCA CCA AA
Human AKT1 ACT GTC ATC GAA CGC ACC TT CTC CTC CTC CTC CTG CTT CT
Human Bcl2 GAA CTG GGG GAG GAT TGT GG GCC GGT TCA GGT ACT CAG TC
NDV-specific reverse-transcription primer [26] AGG GTT CCC GTT CAT TCA G
Page 4 of 13Chu et al. Vet Res           (2019) 50:27 
different experiments, and the data were analyzed using 
GraphPad Prism 5 software.
Results
At the single‑cell level, NDV selectively infects proliferating 
cells
To study whether NDV can selectively infect proliferating 
cells, we investigated the NDV infection frequencies for 
HeLa cells in vitro. To further determine the differences 
between infected and uninfected cells, we used the La 
Sota NDV strain. Fluorescence staining revealed an inho-
mogeneous distribution of GFP (NDV)-positive HeLa 
cells after 16  h of infection with the La Sota virus (0.1 
multiplicity of infection: MOI); however, the cell density 
rapidly decreased around the cluster (Additional file  1). 
This phenomenon might be due to the adherent growth 
characteristic of the cells such that the cells around the 
cluster had more space to proliferate. At 16 h post-infec-
tion (hpi), the numbers of BrdU-positive cells and NDV-
positive cells were examined by immunofluorescence 
staining. In HeLa cells (Figure  1A), a proportion of the 
cells showed dual-positive NDV(GFP) and BrdU(RFP) 
staining, some cells showed single-positive staining, and 
some cells showed dual-negative staining. Next, we sta-
tistically analyzed the proportion of BrdU-positive cells 
among NDV-positive cells and the total cell population. 
Figure 1 A lentogenic NDV strain (La Sota) selectively infects proliferating cells. A Immunofluorescence analysis and quantification of NDV 
and BrdU staining in HeLa cells infected with the lentogenic NDV La Sota strain (0.1 MOI) and labeled with BrdU (5 μM) at 12 hpi. Scale bar, 20 μm. 
Data are presented as the mean ± SD of triplicate samples from three independent experiments. *P < 0.05 by t-test. B qRT-PCR analysis of NDV M 
gene expression normalized to β-actin expression in HeLa cells infected with different viral titers and treated with different concentrations of BrdU 
(0, 2, 5 and 10 μM). Data are presented as the mean ± SD of triplicate samples from four independent experiments. C Flow cytometry for cell cycle 
analysis of HeLa cells infected with NDV (0.1 MOI). D Fluorescein-labeled SNA and MAL1 were used to detect Sia expression on the surface of HeLa 
cells. E FACS analysis of HeLa cells colabeled with PI and either SNA or MAL1.
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The results show that in HeLa cells, 89.7% of the NDV-
positive HeLa cells are BrdU positive, while only 76.7% 
of all cells are BrdU positive (Figure 1A). We then tested 
the influence of BrdU on NDV replication, and the rela-
tive q-PCR results suggest that BrdU had no significant 
effect on the total viral RNA transcript levels at 16 hpi 
(Figure 1B). Additionally, the 50% tissue culture infective 
dose (TCID 50) and viral plaque results show no signifi-
cant differences among the four groups. By contrast, cell 
proliferation was inhibited when we infected the cells 
with NDV (0.1 MOI; 24 h infection) (Figure 1C), suggest-
ing that NDV infection may not enhance the proliferation 
of infected cells. It has been reported that Sia receptors 
mediate NDV entry into host cells [27]. We hypothesized 
that differences in the density of Sia receptors between 
different cells may correlate with the cell selectivity of 
NDV. We used fluorescein-labeled SNA and MAL1 to 
detect the Sia receptor on the surface of HeLa cells. 
Under confocal microscopy, we found that both SNA and 
MAL1 binding was strongly positive in HeLa cells (Fig-
ure 1D). To determine whether NDV is able to selectively 
infect cells during a specific phase of the cell cycle at the 
single-cell level, we labeled the cells with either SNA or 
MAL1 and PI and then used flow cytometry to detect 
the Sia receptor density according to the cell cycle stage. 
The results suggest that the Sia receptor density is higher 
during S/G2 phase than during the G1 phase (Figure 1E), 
which may explain why NDV selectively infects actively 
proliferating cells.
Some NDV strains have been reported to be oncolytic 
viruses [28]. To understand whether NDV strain differ-
ences affect the selection of proliferating cells, we per-
formed experiments with NDV F48E9 strain. For the 
virulent NDV strain F48E9 which can induce cell fusion 
post-infection, we inoculated cells with a low viral titer 
(0.01 MOI) and used the same BrdU dosage as that in the 
above experiments. At 12 hpi, we verified the results by 
immunofluorescence staining. Among the treated HeLa 
cells, 81.35% of NDV-positive HeLa cells were BrdU posi-
tive, and only 52.74% of all HeLa cells were BrdU positive 
(Figure 2). Based on these results, we conclude that NDV 
selectively infects growing cells independent of the viral 
strain.
NDV selectively infects HeLa cells rather 
than neuraminidase‑treated HeLa cells
To determine if Sias were necessary for the selection 
of NDV, we treated HeLa cells with neuraminidase 
(N7790, Solarbio, China) that could remove Sias. The 
cells were incubated with a concentration of neurami-
nidase (10  μg/mL) for 7  days, and the extent of α2,3- 
and α2,6-sialylation was assessed using the specific 
carbohydrate-binding lectins MAL1 and SNA, respec-
tively. There were no cell morphological (Figure  3A) 
or growth (Additional file  2) differences between 
untreated HeLa and neuraminidase-treated HeLa 
(HeLa(E)) cells. Treatment with neuraminidase dramat-
ically blocked the expression of α2,3- and α2,6-linked 
Sias significantly (Figure  3B). Next, we measured the 
difference of infectivity between HeLa and HeLa(E) 
cells by coculture assays. At 24 h post-transfection, dif-
ferent HeLa cells (at a 1:1 ratio) were cocultured with 
red fluorescent (RFP)-expressing HeLa cells for 8  h 
and then infected with NDV (0.5 MOI). This was fol-
lowed by immunostaining for NDV and RFP protein 
and quantification of the percentage of  NDV+RFP+ 
 (GFP+RFP+) cells in the  NDV+  (GFP+) cell population 
by flow cytometry (Figure 3C). The fluorescence results 
suggest that in the mixed culture system of HeLa and 
HeLa-RFP cells, NDV-infected cells without bias (the 
Figure 2 A virulent NDV strain (F48E9) selectively infects proliferating cells. Immunofluorescence analysis and quantification of NDV and 
BrdU staining in HeLa cells infected with the virulent NDV strain F48E9 (0.01 MOI) and labeled with BrdU (5 μM) at 12 hpi. Scale bar, 20 μm. Data are 
presented as the mean ± SD of triplicate samples from three independent experiments. **P < 0.01 by t-test.
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arrow indicates NDV-infected HeLa-RFP cells). How-
ever, in the mixed culture system of HeLa-RFP and 
HeLa(E) cells, NDV more frequently infected the HeLa-
RFP cells (more  GFP+RFP+ cells in the field of view) 
(Figure  3D). To further characterize the selectivity of 
HeLa cells for NDV infection, FACS analysis was used 
to statistically determine the proportion of infected 
cells. In the HeLa-RFP and HeLa mixed groups, the 
percentage of  NDV+RFP+ cells in the  NDV+ cell popu-
lation (approximately 15%) was lower than that in the 
 NDV+ HeLa-RFP and HeLa(E) mixed group population 
(approximately 37%) (Figure  3E). The results indicate 
that Sia is important for NDV infection.
Figure 3 NDV selectively infects HeLa cells but not neuraminidase‑treated HeLa cells. A Morphologic observation of untreated and 
neuraminidase-treated HeLa cells. B The presence of sialic acid was detected in neuraminidase-treated HeLa cells by FACS analysis; cells treated 
without neuraminidase were used as controls. Data are presented as the mean ± SD of triplicate samples from three independent experiments. 
***P < 0.001 by t-test. C Schematic of the coculture assay. D Fluorescence microscopy images of NDV (GFP) and RFP expression in cocultured cells. 
Scale bars represent 50 μm. E Flow cytometry analysis of RFP and GFP expression in HeLa-RFP/HeLa and HeLa-RFP/neuraminidase-treated HeLa 
cells. Numbers indicate the percentage of cells. n = 3 per group of four analyses. Data are presented as the mean ± SD of triplicate samples from 
three independent experiments. **P < 0.01 by t-test.
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Despite the presence of BHK cells, NDV selectively infects 
HeLa cells
To further verify the different amounts of Sias on the 
surface of different cell types, FACS analysis was used 
to compare the fluorescence intensity among a variety 
of HeLa and BHK cells (Figure  4A). The fluorescence 
intensities of both Sia markers were generally higher 
in HeLa cells than in BHK cells, suggesting that HeLa 
cells express more Sia receptors for NDV recognition. 
It is possible that cells were infected by NDV but that 
the expression of NDV-related proteins was delayed. To 
explore this possibility, we infected HeLa and BHK cells 
with La Sota (0, 1, 10, 100 and 1000 MOI) for 6  h and 
conducted fluorescence staining. As illustrated in the 
fluorescence images, the numbers of GFP-positive cells 
(NDV-positive) profoundly decreased with the reduction 
in NDV titers. The replication of NDV occurred earlier 
in BHK cells than in HeLa cells even at the same virus 
dose (Figure  4B). At 16 hpi, aside from GFP-positive 
cell division or migration, there was no increase in the 
number of GFP-positive cells (data not shown), suggest-
ing that at 16 hpi, almost all viruses in the infected cells 
had initiated transcription and replication. It has been 
reported that the La Sota strain of NDV kills cancer cells 
in  vitro with high selectivity [29], and we hypothesized 
that NDV can infect based on Sia expression patterns and 
can select specific cells in cultures containing different 
cell types in vitro. To test this hypothesis, we used cocul-
ture assays with BHK-RFP cells to measure the differ-
ence in NDV selectivity between HeLa and BHK cells. At 
24 h post-transfection, different HeLa or BHK cells were 
cocultured with BHK-RFP cells for 8 h. Considering the 
difference in cell growth between BHK and HeLa cells 
(Additional file 2), we added BHK and HeLa cells at a 1:2 
ratio and then infected the mixed cultures with NDV (0.5 
MOI). This was followed by immunostaining for NDV 
and RFP protein and quantification of the percentage of 
 NDV+RFP+  (GFP+RFP+) cells in the  NDV+  (GFP+) pop-
ulation by flow cytometry (Figure 4C). The fluorescence 
results suggest that in the mixed culture system compris-
ing BHK and BHK-RFP cells, NDV-infected cells without 
bias (the arrow indicates NDV-infected BHK-RFP cells). 
However, in the mixed culture system comprising BHK-
RFP and HeLa cells, NDV more frequently infected HeLa 
cells (Figure  4D). To further characterize the selectivity 
of HeLa cells for NDV infection, we used FACS analysis 
to statistically determine the proportion of infected cells. 
In the BHK and BHK-RFP mixed culture groups, the per-
centage of  NDV+RFP+ cells in the  NDV+ cell population 
(approximately 12%) was higher than that in the  NDV+ 
cell population from the BHK-RFP and HeLa mixed cul-
ture groups (approximately 3%) (Figure 4E).
Considering that RFP expression in cells may affect the 
infectious ability of NDV, we repeated the exercise using 
HeLa-RFP cells similar to the experiment depicted in Fig-
ure 5C (Figure 4F). The fluorescence results suggest that 
in a mixed culture system of HeLa and HeLa-RFP cells, 
NDV infected the cells without bias (the arrow indicates 
NDV-infected HeLa-RFP cells, yellow cells). However, 
in the mixed culture system comprising HeLa-RFP and 
BHK cells, NDV more frequently infected HeLa-RFP 
cells (more yellow cells in view) (Figure 4G). FACS analy-
sis shows that in the BHK and HeLa-RFP mixed culture 
group, the percentage of  NDV+RFP+ cells in  NDV+ cell 
population (approximately 15%) was higher than that in 
the  NDV+ cell population from the HeLa-RFP and HeLa 
mixed culture group (approximately 5%) (Figure  4H). 
This result indicates that NDV displays host tropism for 
cells that express more Sia.
Select proliferating cells promote virus replication
To further elucidate whether the selection of proliferating 
cells by NDV benefits the virus replication, we conducted 
the following experiments. Given that cell prolifera-
tion requires a nutrient supply to control the rate of 
cell growth, we reduced the concentration of FBS in the 
culture medium. After incubating the cells in different 
culture media for 12  h, the cell proliferation index was 
calculated. BrdU immunofluorescence staining of those 
cells produced similar results: the proportion of BrdU-
positive cells increased with increasing FBS concentra-
tions (Figure  5A). Flow cytometry was used to examine 
the effects of serum on cell cycle progression, and the 
results suggest that when the FBS concentration in the 
culture medium was increased (to no more than 10%), 
the proportion of HeLa cells in G1 phase decreased (Fig-
ure 5B). This result indicates that cell proliferation can be 
affected by the concentration of FBS. Apoptosis is widely 
thought to suppress the host cell’s response to NDV rep-
lication. In the above experiment, we treated cells with 
different concentrations of FBS to control the growth 
rate, but serum starvation might lead to cell apoptosis 
[30]. We detected apoptosis after changing the medium, 
and our results suggest that short-term treatment of the 
cells with medium either lacking FBS or containing a low 
concentration of FBS for 12 h did not lead to significant 
apoptosis of HeLa cells (Figure 5C). Therefore, the differ-
ent replication abilities of NDV under different nutrient 
conditions appear not to be affected by apoptosis.
To determine the influence of cell proliferation on 
NDV replication, we infected HeLa cells with the La 
Sota NDV strain (1 MOI). At 24 hpi, real-time fluores-
cence q-PCR was used to measure the total viral RNA 
levels in cell lysates and conditioned media. Compared 
with the serum-free and low-FBS-supplemented groups, 
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Figure 4 NDV selectively infects HeLa cells. A The presence of sialic acid was detected in HeLa and BHK cells by FACS analysis; unstained cells 
were used as a blank control. B Fluorescence microscopy images of NDV  (GFP+) cells treated with different viral titers of NDV. Scale bars represent 
50 μm. C Schematic of the coculture assay. D Fluorescence microscopy images of NDV  (GFP+) and RFP in cocultured cells; the arrow indicates 
an NDV-infected BHK-RFP cell. Scale bars represent 50 μm. E Flow cytometry was used to analyze RFP and GFP expression in BHK-RFP/HeLa and 
BHK-RFP/BHK cell cocultures. Numbers reflect the percentage of cells. Data are presented as the mean ± SD of triplicate samples from three 
independent experiments. **P < 0.01 by t-test. F Schematic of the coculture assay. G Fluorescence microscopy images of NDV (GFP) and RFP in 
cocultured cells; the arrow indicates an NDV-infected HeLa-RFP cell. Scale bars represent 50 μm. H Flow cytometry was used to analyze RFP and GFP 
expression in HeLa-RFP/HeLa and HeLa-RFP/BHK cell cocultures. Numbers reflect the percentage of cells. Data are presented as the mean ± SD of 
triplicate samples from three independent experiments. *P < 0.05 by t-test.
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Figure 5 Proliferating cells enhance NDV replication. HeLa cells were cultured with different concentrations of FBS for 24 h and then stained 
with BrdU (A), after which cell cycle distribution (B) and apoptosis (C) were analyzed by flow cytometry. Cells were pretreated with different 
concentrations of serum for 24 h and then infected with NDV. At 24 hpi, viruses were quantified by qRT-PCR based on M gene expression (D) and 
titration with plaque assay (E). Data are presented as the mean ± SD of triplicate samples from four independent experiments. **P < 0.01 by t-test.
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the control group shows higher viral RNA levels in vig-
orously growing cells (Figure 5D). The plaque test shows 
similar trends between the F48E9 and La Sota NDV 
strains (Figure 5E). These results suggest that NDV repli-
cation increased with increasing proportions of cells in S 
and G2 phase, suggesting that selective infection of NDV 
in dividing cells benefits NDV replication.
Increased NDV replication leads to more serious damage
Apoptosis has been identified as a major hallmark of 
NDV-mediated cytotoxicity in virally infected cells [1]. 
NDV-induced apoptosis requires virus entry, replication 
and de novo protein synthesis [31]. Our results suggest 
that NDV selectively infects growing cells to produce 
more viral copies, and we speculated that stronger viral 
replication could more strongly induce apoptosis. To test 
our hypothesis, cells were infected with NDV (La Sota 
strain) at different MOI for 48  h. Western blot analysis 
shows that when cells were infected with the La Sota 
NDV strain (0.1 MOI) for 48  h, HeLa cells exhibited 
notable apoptosis based on the changes in the relative 
expression of apoptosis-related proteins (BAX, Bcl2, 
cleaved caspase-3) (Figure  6A). The q-PCR results sug-
gest that caspase-3 expression was increased in HeLa 
cells from the NDV-infected group (0.1 MOI) at 48 hpi 
compared to that in cells from the control group (Fig-
ure 6B). The flow cytometry results were consistent with 
the hypothesis that NDV infection of the cells at a higher 
MOI would increase apoptosis (Figure 6C). The cytotox-
icity of NDV to cells is known to be due to its ability to 
activate multiple caspase-dependent pathways of apopto-
sis [3]. These results indicate that cells with a higher pro-
liferative capacity will produce more virus, while more 
virus replication will lead to more pronounced apoptosis 
(Figure 6D).
Discussion
For the cell selection mechanism of NDV at the single-
cell level, we observed that NDV tends to infect cells in 
the S/G2 phase (Figure 2). To our knowledge, there are no 
reports about the relationship between the cell cycle and 
changes in Sia dynamics. Our findings suggest that cells 
in the S/G2 phase have a higher receptor density than do 
cells in the G1 phase (Figure 2), which may explain why 
NDV selectively infected BrdU-positive cells in single-
cell cultures. No study has reported on differences in cell 
selectivity between different NDV strains. In our work, 
both the virulent F48E9 strain and the lentogenic La Sota 
strain selectively infected proliferating cells, but their 
potencies in selecting proliferating cells differed (Fig-
ures 2, 3). NDV selectively infects dividing cells in HeLa 
and BHK cell cultures, but the ratios were not exactly 
the same. Thus, we conclude that the capability of select-
ing S/G2 phase cells is a common characteristic of NDV 
that may vary according to the cell type and NDV strain. 
Based on this method, an evaluation system for screening 
of the oncolytic NDV strain may be established.
As extensively demonstrated in  vitro and in accord-
ance with a classic rule of thermodynamics, the more 
attachment factors or receptors that are present at the 
cell surface and the higher the affinity of a virus with 
these receptors, the more efficient the primary inter-
action is [32]. It is well known that different cell types 
express distinct receptor types at specific quantities. In 
our study, NDV preferentially infected HeLa cells rela-
tive to HeLa(E) and BHK cells, and HeLa cells expressed 
SNA- and MAL1-labeled Sia receptors on their surface 
more abundantly than did HeLa(E) and BHK cells (Fig-
ures 4 and 5); this difference may be why NDV selectively 
infected HeLa cells. In addition, it has been reported 
that α2,6-linked Sia functions as a high-affinity receptor 
with NDV in oncolytic virotherapy [33]. BHK cells lack 
α2,6-linked Sia (Figure 5A), which may be another reason 
NDV selected HeLa cells. Normal cells were found to be 
resistant to NDV replication. Therefore, we investigated 
the relationship between cell proliferation and viral rep-
lication. Our results suggest that cell proliferation is ben-
eficial to viral replication (Figure 6). It has been reported 
that the nutrient/physical status of the host links innate 
immunity to antiviral host defense and that a higher 
nutrient status increases virus replication [34]. In our 
study, we used different concentrations of FBS to regu-
late cell growth and found that cells with a higher prolif-
erative ability exhibited increased virus replication. These 
results suggest that NDV replication may be affected by 
the nutrient/physical status of the host cell.
Viruses have evolved to manipulate and take control 
of the programmed cell death response, but the infected 
cell attempts to neutralize viral infections by activa-
tion of different stress signals and defensive pathways to 
antagonize the virus-induced cell self-destruction [35]. 
The inherent anti-tumor capacity of NDV combines two 
characteristics that delineate what can be defined as the 
oncolytic paradigm: NDV promotes the induction of 
tumor cell death accompanied by the elicitation of anti-
tumor immunity [1]. Both extrinsic and intrinsic apop-
totic pathways can be activated in cancer cells after NDV 
infection [2], and apoptosis dominantly contributes to 
NDV induced cell death [2–4, 36]. In lung cancer cells, 
higher virus particles infecting the cell corresponded to 
more cell death [37]. In our experiments, apoptosis was 
more extensive in HeLa cells infected with NDV at a high 
MOI than in cells infected with NDV at a low MOI (Fig-
ure 6). Therefore, we conclude that NDV selects dividing 
cells for infection and replication, leading to apoptosis 
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of those dividing cells. NDV has the ability to selectively 
kill apoptosis-resistant cells [38]. In our study, we found 
that cell proliferation was not positively correlated with 
cell apoptosis (Figure  6), suggesting that the selection 
of proliferating cells by NDV is independent of apopto-
sis resistance. Tumor cells have a lower capacity to resist 
NDV replication, and another reason may be that tumor 
cells have a lower interferon level [39, 40] or are resistant 
to apoptosis [38]. Given the limitations of materials and 
methods in this study, we did not measure the interferon 
concentration at the single-cell level. Here, we show the 
selectivity of NDV among the same cells in one culture 
dish grown in cell culture medium containing the same 
interferon concentration, suggesting that the selection of 
proliferating cells by NDV is independent of the extent of 
interferon resistance.
In general, our results suggest that in one cell type, 
NDV tends to infect cells during the S/G2 phase in the 
Figure 6 Increased NDV replication leads to more cell apoptosis. A Western blot analysis of the expression of apoptosis-related proteins (BAX, 
Bcl2 and caspase-3) in HeLa cells at 48 hpi (0.1 MOI; La Sota). B qRT-PCR analysis of apoptosis-related gene expression in HeLa cells at 48 hpi (0.1 
MOI; La Sota). C Flow cytometry analysis of cell apoptosis at 48 hpi (0.1, 1 or 2 MOI); data are pooled from replicates of at least three independent 
experiments. D Overall description of how NDV selectively infects proliferating cells to kill tumor cells. Data are presented as the mean ± SD of 
triplicate samples from a single experiment and are representative of three independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 by t-test.
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absence of interference from other cell types. Moreover, 
the selective infection of dividing cells by NDV benefited 
its replication, and enhanced NDV replication in cells 
with increased cell damage (Figure 6D).
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Additional file 1. NDVselectively infects proliferating HeLa cells. (A) 
Immunofluorescence for NDV (0.1 MOI) revealed an uneven distribution 
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for BrdU revealed an uneven distribution of infected HeLa cells. Scale bar, 
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